Considerations in prescribing pharmacotherapy for localized and metastatic urothelial carcinoma

Expert Opin Pharmacother. 2021 Jan;22(1):1-4. doi: 10.1080/14656566.2020.1813717. Epub 2020 Aug 31.

Authors

Praful Ravi¹, Guru P Sonpavde¹

Affiliation

¹ Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute , Boston, MA, USA.

PMID: 32866395
DOI: 10.1080/14656566.2020.1813717

No abstract available

Keywords: Urothelial cancer; antibody-drug conjugates; chemotherapy; immunotherapy; targeted therapy.

Publication types

Editorial

MeSH terms

Carcinoma, Transitional Cell*
Humans
Immunotherapy
Urinary Bladder Neoplasms* / drug therapy